Abstract:Xeroderma pigmentosum (XP) is a rare autosomal recessive disease caused by pathogenic variants in seven nucleotide excision repair genes (XPA to XPG) and POLH involved in translesion synthesis. XP patients have a >1000-fold increased risk for sunlight-induced skin cancers. Many Japanese XP-A patients have severe neurological symptoms due to a founder variant in intron 3 of the XPA gene. However, in the United States we found XP-A patients with milder clinical features. We developed a simple scoring scale to assess XP-A patients of varying neurological disease severity. We report 18 XP-A patients examined between 1973 and 2023 under an IRB approved natural history study. Using our scale, we classified our XP-A cohort into severe (n = 8), intermediate (n = 5), and mild (n = 5) disease groups at age 10 years. DNA repair tests demonstrated greatest reduction of DNA repair in cells from severe patients as compared to cells from mild patients. Nucleotide sequencing identified 18 germline pathogenic variants in the 273 amino acid, 6 exon-containing XPA gene. Based on patient clinical features, we associated these XPA variants to severe (n = 8), intermediate (n = 6), and mild (n = 4) clinical phenotypes in the patients. Protein structural analysis showed that nonsense and frameshift premature stop codon pathogenic variants located in exons 3 and 5 correlated with severe disease. Intermediate disease correlated with a splice variant at the last base in exon 4. Mild disease correlated with a frameshift variant in exon 1 with a predicted re-initiation in exon 2; a splice variant that created a new strong donor site in intron 4; and a large genomic deletion spanning exon 6. Our findings revealed correlations between disease severity, DNA repair capacity, and XPA variant type and location. In addition, both XPA alleles contributed to the phenotypic differences in XP-A patients. Xeroderma pigmentosum, (XP), is a rare autosomal recessive inherited disease. Exposure to ultraviolet radiation greatly increases the risk of developing skin cancers and premature aging features in XP patients. In Japan, most XP-A patients have a founder variant in intron 3 of the XPA gene and experience severe neurological symptoms and death at an early age. However, in our cohort we identified different germline variants in the XPA gene associated with severe and mild clinical features in the patients. To assess XP-A patients with a wider range of disease severity, we developed a simple neurological scoring scale. Using an age of evaluation of 10 years, we categorized phenotypic differences among our 18 XP-A patients and classified them into severe, intermediate, and mild disease groups. Using this scale, we associated these 18 pathogenic variants with severe (n = 8), intermediate (n = 6), and mild (n = 4) clinical phenotypes in the XP-A patients. As a result, our scale helps predict neurological severity and mortality, making it a useful tool for general clinical practice and genotype-phenotype studies. This allowed us to correlate neurological severity with the type, location, and cellular function of XPA germline pathogenic variants.

Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition

XPC Polymorphism Increases Risk of Digestive System Cancers： Current Evidence from A Meta-Analysis

Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma.

XPG Gene Polymorphisms and Cancer Susceptibility: Evidence from 47 Studies.

Polymorphisms In Excision Repair Cross-Complementing Group 4 (Ercc4) And Susceptibility To Primary Lung Cancer In A Chinese Han Population

Association Between XPA Gene Rs1800975 Polymorphism and Susceptibility to Lung Cancer: a Meta-Analysis

XPA Polymorphism Associated with Reduced Lung Cancer Risk and a Modulating Effect on Nucleotide Excision Repair Capacity

A Tandem Repeat of Human Telomerase Reverse Transcriptase (htert) and Non Small Cell Lung Cancer Development and Survival in Chinese Population

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients

Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations

Xeroderma Pigmentosum Group D Polymorphisms and Esophageal Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.

XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms

Comparative evaluation of XPD and XPG gene polymorphism in oral squamous cell carcinoma and tobacco chewers: An observational study

Associations Between Polymorphisms of the XPC Gene and Lung Cancer Susceptibility: a Meta-Analysis.

The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies

Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients

Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts

XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature

Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study

Identification of a ERCC5 c.2333T>C (L778P) Variant in Two Tunisian Siblings With Mild Xeroderma Pigmentosum Phenotype

The relationship between XPG rs 17655 polymorphism and the risk of lung cancer